Previous prediction models and recommendations primarily referred to other cardiovascular diseases - suitable predictions for PAVK patients were impossible. People with PAVD suffer from circulatory disorders in the extremities.
Health insurance data from almost 82,000 patients with PAVK who were hospitalised between 2010 and 2018 were used to calculate the risk score. The risk score was developed and internally validated using machine learning techniques on a training data set. It became clear that about 2.2 per cent of the patients had complications after one year. Most of these were gastrointestinal bleeding requiring inpatient treatment.
"We hope that calculation of the bleeding risk of the patients will help in the complementary therapy and follow-up of this chronic, widespread disease. The risk score is currently being validated in England, France, the USA and Sweden," says the first author of the study and DZHK scientist Priv.-Doz. Dr. Christian-Alexander Behrendt from the Clinic and Polyclinic for Vascular Medicine.
Eight independent risk factors are included in the calculation of the 1-year risk: oral anticoagulation, advanced age (over 80 years), chronic limb-threatening ischaemia (Fontaine stages III and IV), chronic heart failure, severe renal insufficiency, previous bleeding event, anaemia, dementia.
The scientists who developed the risk score are currently developing a European guideline on antithrombotic therapy for vascular diseases.
Publication: CA. Behrendt et al. The OAC3-PAD Risk Score Predicts Major Bleeding Events one Year after Hospitalisation for Peripheral Artery Disease. Eur J Vasc Endovasc Surg., online ahead of print, 2022. DOI: https://doi.org/10.1016/j.ejvs.2021.12.019
Scientific Contact: Priv.-Doz. Dr. Christian-Alexander Behrendt, Clinic and Polyclinic for Vascular Medicine
Source: Press Release University Hospital Hamburg-Eppendorf (UKE)